GREEN SIGNAL! Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG
The Defence Research and Development Organisation (DRDO) has approved Mankind Pharma to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19, said the drug firm on Thursday.
"Our objective behind this agreement is to ensure maximum reach of this medication to the deserving Indian patients suffering from the deadly pandemic," news agency PTI quoted Mankind Pharma. Source: Pixabay